ACADIA Pharmaceuticals Income Statement
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 7.6 | 8.1 | 11.0 |
| Cost of Goods Sold | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| Gross Profit Margin | 0.0% | 0.0% | 0.0% |
| SG&A Expense | 69.4 | 57.3 | 45.7 |
| Depreciation & Amortization | 0.8 | (0.2) | 1.0 |
| Operating Income | (62.7) | (49.0) | (35.8) |
| Operating Margin | -- | -- | -- |
| Nonoperating Income | 6.5 | 4.2 | 1.9 |
| Nonoperating Expenses | 0.3 | 0.2 | 0.2 |
| Income Before Taxes | (56.4) | (45.1) | (34.1) |
| Income Taxes | -- | -- | -- |
| Net Income After Taxes | (56.4) | (45.1) | (34.1) |
| Continuing Operations | (56.4) | (45.1) | (34.1) |
| Discontinued Operations | -- | 0.1 | -- |
| Total Operations | (56.4) | (45.0) | (34.1) |
| Total Net Income | (56.4) | (45.0) | (34.1) |
| Net Profit Margin | -- | -- | -- |
| Diluted EPS from Total Net Income ($) | (1.60) | (1.61) | (1.55) |
| Dividends per Share | -- | -- | -- |
This data is provided as per license from EDGAR Online
